South Africa Embolotherapy Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Embolic Agents and Support Devices), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Diseases, Urological & Nephrological Disorders, Gastrointestinal Disorders, and Others), Procedure (Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)), and End User (Hospitals & Clinics, Ambulatory Surgery Centers, and Other End Users)

No. of Pages: 163    |    Report Code: BMIRE00025506    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South Africa Embolotherapy Market

1.     INTRODUCTION

            1.1.       SCOPE OF THE STUDY

            1.2.       THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

            1.3.       MARKET SEGMENTATION

                         1.3.1   Embolotherapy Market - By Product

                         1.3.2   Embolotherapy Market - By Disease Indication

                         1.3.3   Embolotherapy Market - By Procedure

                         1.3.4   Embolotherapy Market - By End User

2.        KEY TAKEAWAYS

3.        RESEARCH METHODOLOGY

4.        EMBOLOTHERAPY MARKET LANDSCAPE

            4.1.       OVERVIEW

            4.2.       PEST ANALYSIS

                         4.2.1        South Africa - Pest Analysis

            4.3.       EXPERT OPINIONS

5.        EMBOLOTHERAPY MARKET - KEY MARKET DYNAMICS

            5.1.       KEY MARKET DRIVERS

            5.2.       KEY MARKET RESTRAINTS

            5.3.       KEY MARKET OPPORTUNITIES

            5.4.       FUTURE TRENDS

            5.5.       IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6.        EMBOLOTHERAPY MARKET - SOUTH AFRICA MARKET ANALYSIS

            6.1.       EMBOLOTHERAPY - SOUTH AFRICA MARKET OVERVIEW

            6.2.       EMBOLOTHERAPY - SOUTH AFRICA MARKET AND FORECAST TO 2028

            6.3.       MARKET POSITIONING

7.        EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 – PRODUCT

            7.1.       OVERVIEW

            7.2.       PRODUCT MARKET FORECASTS AND ANALYSIS

            7.3.       EMBOLIC AGENTS

                          7.3.1.         Overview

                          7.3.2.         Embolic Agents Market Forecast and Analysis

                          7.3.3.         Microspheres Market

                                            7.3.3.1.        Overview

                                            7.3.3.2.        Microspheres Market Forecast and Analysis

                          7.3.4.          Embolic Coils Market

                                            7.3.4.1.        Overview

                                            7.3.4.2.         Embolic Coils Market Forecast and Analysis

                          7.3.5.          Liquid Embolic Agents Market

                                            7.3.5.1.        Overview

                                            7.3.5.2.         Liquid Embolic Agents Market Forecast and Analysis

                          7.3.6.          Embolic Plug Systems Market

                                            7.3.6.1.        Overview

                                            7.3.6.2.         Embolic Plug Systems Market Forecast and Analysis

                          7.3.7.          Detachable Balloons Market

                                            7.3.7.1.        Overview

                                            7.3.7.2.         Detachable Balloons Market Forecast and Analysis

            7.4.       SUPPORT DEVICES

                          7.4.1.         Overview

                          7.4.2.         Support Devices Market Forecast and Analysis

                          7.4.3.         Microcatheters Market

                                            7.4.3.1.        Overview

                                            7.4.3.2.        Microcatheters Market Forecast and Analysis

                          7.4.4.          Guidewires Market

                                            7.4.4.1.        Overview

                                            7.4.4.2.         Guidewires Market Forecast and Analysis

8.        EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 – DISEASE INDICATION

            8.1.       OVERVIEW

            8.2.       DISEASE INDICATION MARKET FORECASTS AND ANALYSIS

            8.3.       CANCER

                          8.3.1.         Overview

                          8.3.2.         Cancer Market Forecast and Analysis

                          8.3.3.         Liver Cancer Market

                                            8.3.3.1.        Overview

                                            8.3.3.2.        Liver Cancer Market Forecast and Analysis

                          8.3.4.          Kidney Cancer Market

                                            8.3.4.1.        Overview

                                            8.3.4.2.         Kidney Cancer Market Forecast and Analysis

                          8.3.5.          Other Cancers Market

                                            8.3.5.1.        Overview

                                            8.3.5.2.         Other Cancers Market Forecast and Analysis

            8.4.       PERIPHERAL VASCULAR DISEASE

                          8.4.1.         Overview

                          8.4.2.         Peripheral Vascular Disease Market Forecast and Analysis

            8.5.       NEUROLOGICAL DISEASES

                          8.5.1.         Overview

                          8.5.2.         Neurological Diseases Market Forecast and Analysis

            8.6.       UROLOGICAL AND NEPHROLOGICAL DISORDERS

                          8.6.1.         Overview

                          8.6.2.         Urological and Nephrological Disorders Market Forecast and Analysis

            8.7.       GASTROINTESTINAL DISORDERS

                          8.7.1.         Overview

                          8.7.2.         Gastrointestinal Disorders Market Forecast and Analysis

9.        EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 – PROCEDURE

            9.1.       OVERVIEW

            9.2.       PROCEDURE MARKET FORECASTS AND ANALYSIS

            9.3.       TRANSCATHETER ARTERIAL EMBOLIZATION (TAE)

                          9.3.1.         Overview

                          9.3.2.         Transcatheter Arterial Embolization (TAE) Market Forecast and Analysis

            9.4.       TRANSCATHETER ARTERIAL RADIOEMBOLIZATION (TARE)/SELECTIVE INTERNAL RADIATION THERAPY (SIRT)

                          9.4.1.         Overview

                          9.4.2.         Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) Market Forecast and Analysis

            9.5.       TRANSARTERIAL CHEMOEMBOLIZATION (TACE)

                          9.5.1.         Overview

                          9.5.2.         Transarterial Chemoembolization (TACE) Market Forecast and Analysis

10.        EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 – END USER

               10.1.       OVERVIEW

               10.2.       END USER MARKET FORECASTS AND ANALYSIS

               10.3.       HOSPITALS AND CLINICS

                             10.3.1.         Overview

                             10.3.2.         Hospitals and Clinics Market Forecast and Analysis

               10.4.       AMBULATORY SURGERY CENTERS

                             10.4.1.         Overview

                             10.4.2.         Ambulatory Surgery Centers Market Forecast and Analysis

               10.5.       OTHER END USERS

                             10.5.1.         Overview

                             10.5.2.         Other End Users Market Forecast and Analysis

11.        IMPACT OF COVID-19 PANDEMIC ON EMBOLOTHERAPY MARKET

               11.1        SOUTH AFRICA

12.        INDUSTRY LANDSCAPE

               12.1.       MERGERS AND ACQUISITIONS

               12.2.       AGREEMENTS, COLLABORATIONS AND JOIN VENTURES

               12.3.       NEW PRODUCT LAUNCHES

               12.4.       EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13.        EMBOLOTHERAPY MARKET, KEY COMPANY PROFILES

               13.1.     ABBOTT LABORATORIES

                              13.1.1.      Key Facts

                              13.1.2.      Business Description

                              13.1.3.      Products and Services

                              13.1.4.      Financial Overview

                              13.1.5.      SWOT Analysis

                              13.1.6.      Key Developments

               13.2.     ACANDIS GMBH

                              13.2.1.      Key Facts

                              13.2.2.      Business Description

                              13.2.3.      Products and Services

                              13.2.4.      Financial Overview

                              13.2.5.      SWOT Analysis

                              13.2.6.      Key Developments

               13.3.     BOSTON SCIENTIFIC CORPORATION

                              13.3.1.      Key Facts

                              13.3.2.      Business Description

                              13.3.3.      Products and Services

                              13.3.4.      Financial Overview

                              13.3.5.      SWOT Analysis

                              13.3.6.      Key Developments

               13.4.     STRYKER CORPORATION

                              13.4.1.      Key Facts

                              13.4.2.      Business Description

                              13.4.3.      Products and Services

                              13.4.4.      Financial Overview

                              13.4.5.      SWOT Analysis

                              13.4.6.      Key Developments

               13.5.     JOHNSON AND JOHNSON

                              13.5.1.      Key Facts

                              13.5.2.      Business Description

                              13.5.3.      Products and Services

                              13.5.4.      Financial Overview

                              13.5.5.      SWOT Analysis

                              13.5.6.      Key Developments

               13.6.     MEDTRONIC

                              13.6.1.      Key Facts

                              13.6.2.      Business Description

                              13.6.3.      Products and Services

                              13.6.4.      Financial Overview

                              13.6.5.      SWOT Analysis

                              13.6.6.      Key Developments

               13.7.     COOK MEDICAL

                              13.7.1.      Key Facts

                              13.7.2.      Business Description

                              13.7.3.      Products and Services

                              13.7.4.      Financial Overview

                              13.7.5.      SWOT Analysis

                              13.7.6.      Key Developments

               13.8.     Guerbet LLC.

                              13.8.1.      Key Facts

                              13.8.2.      Business Description

                              13.8.3.      Products and Services

                              13.8.4.      Financial Overview

                              13.8.5.      SWOT Analysis

                              13.8.6.      Key Developments

               13.9.     BALT EXTRUSION

                              13.9.1.      Key Facts

                              13.9.2.      Business Description

                              13.9.3.      Products and Services

                              13.9.4.      Financial Overview

                              13.9.5.      SWOT Analysis

                              13.9.6.      Key Developments

               13.10.     TERUMO CORPORATION

                              13.10.1.      Key Facts

                              13.10.2.      Business Description

                              13.10.3.      Products and Services

                              13.10.4.      Financial Overview

                              13.10.5.      SWOT Analysis

                              13.10.6.      Key Developments

14.        APPENDIX

               14.1.       ABOUT THE INSIGHT PARTNERS

               14.2.       GLOSSARY OF TERMS

 

LIST OF TABLES

Table 1.South Africa. Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2.South Africa. Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 3.South Africa. Embolotherapy Market, by Procedure – Revenue and Forecast to 2028 (US$ Million)

Table 4.South Africa. Embolotherapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5.Organic Developments Done By Companies

Table 6.Inorganic Developments Done by Companies

Table 7.Glossary of Terms, Embolotherapy Market

 

The List of Companies - South Africa Embolotherapy Market

  1. Abbott Laboratories           
  2. Boston Scientific Corporation         
  3. Cook Medical LLC                
  4. Johnson & Johnson Consumer Inc                
  5. Medtronic              
  6. Acandis GmbH     
  7. Terumo Corporation          
  8. Balt USA LLC          
  9. Stryker Corporation           
  10. Guerbet LLC.